This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Read, T.-A. et a. Nat. Biotechnol. 19, 29– 34 (2001).
Joki, et al. Nat. Biotechnol. 19, 35–39 ( 2001).
Martinsen, A., Skjak-Brak, G. & Smidsørd, O. Biotechnol. Bioeng. 33, 79–89 (1989).
Folkman, J. In Cancer medicine, Edn. 5 (eds Holland, J.F. & Frei, E.) 132 –152 (B.C. Decker Inc. Hamilton, London; 2000).
US National Cancer Institute. Cancer Trials Web Site: http://cancertrials.nci.nih.gov/news/angio/angiomore.html
http://www.entremed.com/products/endo_human_trials.html
http://www.entremed.com/news/preleases/endo110900.html
http://www.entremed.com/news/preleases/endo111000.html
Feldman, A.L. & Libutti, S.K. Cancer 89, 1181–1194 (2000).
Aboody K.S. et al. Proc. Natl. Acad. Sci. USA 97,12846 –12851 (2000).
Lim, F. & Sun, A.M. Science 210, 908–910 (1980).
Hanahan, D., Bergers, G. & Bergsland, E. J. Clin. Invest. 105, 1045– 1047 (2000).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Bergers, G., Hanahan, D. Cell factories for fighting cancer. Nat Biotechnol 19, 20–21 (2001). https://doi.org/10.1038/83457
Issue Date:
DOI: https://doi.org/10.1038/83457
This article is cited by
-
Cancer nanotechnology: opportunities and challenges
Nature Reviews Cancer (2005)
-
Cell-based therapies go live
Nature Biotechnology (2002)